Recommends 13 actions that policy-makers, courts, universities, and health and patent officials should take to prevent the complex web of IP protections from getting in the way of potential breakthroughs in genomic and proteomic research. This report urges patent holders to allow others to perform the tests for purposes of verifying the results.